Compass Net Borrowings vs Capital Expenditures Analysis

CMPX Stock  USD 1.63  0.07  4.49%   
Compass Therapeutics financial indicator trend analysis is way more than just evaluating Compass Therapeutics prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Compass Therapeutics is a good investment. Please check the relationship between Compass Therapeutics Net Borrowings and its Capital Expenditures accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Compass Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
For more information on how to buy Compass Stock please use our How to Invest in Compass Therapeutics guide.

Net Borrowings vs Capital Expenditures

Net Borrowings vs Capital Expenditures Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Compass Therapeutics Net Borrowings account and Capital Expenditures. At this time, the significance of the direction appears to have almost identical trend.
The correlation between Compass Therapeutics' Net Borrowings and Capital Expenditures is 0.9. Overlapping area represents the amount of variation of Net Borrowings that can explain the historical movement of Capital Expenditures in the same time period over historical financial statements of Compass Therapeutics, assuming nothing else is changed. The correlation between historical values of Compass Therapeutics' Net Borrowings and Capital Expenditures is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Borrowings of Compass Therapeutics are associated (or correlated) with its Capital Expenditures. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Capital Expenditures has no effect on the direction of Net Borrowings i.e., Compass Therapeutics' Net Borrowings and Capital Expenditures go up and down completely randomly.

Correlation Coefficient

0.9
Relationship DirectionPositive 
Relationship StrengthVery Strong

Net Borrowings

The difference between the amount of new debt a company has taken on and the amount of debt it has paid off during a given period.

Capital Expenditures

Capital Expenditures are funds used by Compass Therapeutics to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Compass Therapeutics operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.
Most indicators from Compass Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Compass Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Compass Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
For more information on how to buy Compass Stock please use our How to Invest in Compass Therapeutics guide.At this time, Compass Therapeutics' Tax Provision is fairly stable compared to the past year. Selling General Administrative is likely to rise to about 12.9 M in 2024, whereas Issuance Of Capital Stock is likely to drop slightly above 3 M in 2024.
 2021 2022 2023 2024 (projected)
Depreciation And Amortization1.6M1.9M1.9M1.7M
Interest Income29K2.4M7.9M8.3M

Compass Therapeutics fundamental ratios Correlations

-0.870.420.670.90.87-0.060.58-0.27-0.850.670.15-0.090.07-0.63-0.751.0-0.790.84-0.770.680.92-0.760.90.890.71
-0.87-0.06-0.61-0.99-1.00.45-0.770.160.99-0.54-0.050.470.120.510.95-0.880.94-0.760.95-0.5-0.970.95-0.99-0.68-0.88
0.42-0.060.510.170.050.60.02-0.640.02-0.080.590.60.08-0.45-0.040.4-0.110.0-0.060.640.2-0.040.170.510.03
0.67-0.610.510.660.6-0.190.54-0.02-0.580.24-0.05-0.2-0.34-0.22-0.620.65-0.570.39-0.610.890.62-0.590.670.450.53
0.9-0.990.170.660.99-0.410.75-0.21-0.960.530.1-0.43-0.07-0.5-0.950.91-0.960.72-0.960.590.97-0.961.00.690.87
0.87-1.00.050.60.99-0.450.73-0.14-0.980.570.03-0.48-0.06-0.49-0.940.88-0.940.76-0.950.50.96-0.950.990.670.86
-0.060.450.6-0.19-0.41-0.45-0.63-0.510.47-0.210.571.00.34-0.450.61-0.080.51-0.220.58-0.13-0.40.59-0.410.32-0.63
0.58-0.770.020.540.750.73-0.63-0.05-0.790.22-0.08-0.64-0.61-0.27-0.870.59-0.720.53-0.830.460.82-0.830.750.350.96
-0.270.16-0.64-0.02-0.21-0.14-0.51-0.050.050.34-0.98-0.51-0.180.710.16-0.270.250.160.19-0.06-0.20.19-0.21-0.48-0.12
-0.850.990.02-0.58-0.96-0.980.47-0.790.05-0.580.060.50.20.490.92-0.860.88-0.820.91-0.45-0.950.92-0.96-0.67-0.88
0.67-0.54-0.080.240.530.57-0.210.220.34-0.58-0.45-0.240.36-0.09-0.360.68-0.440.88-0.390.390.58-0.390.530.50.38
0.15-0.050.59-0.050.10.030.57-0.08-0.980.06-0.450.570.2-0.67-0.050.14-0.14-0.28-0.08-0.050.06-0.080.10.4-0.03
-0.090.470.6-0.2-0.43-0.481.0-0.64-0.510.5-0.240.570.35-0.420.62-0.110.53-0.250.6-0.14-0.430.61-0.440.29-0.64
0.070.120.08-0.34-0.07-0.060.34-0.61-0.180.20.360.20.350.020.250.07-0.030.010.16-0.09-0.120.16-0.070.1-0.37
-0.630.51-0.45-0.22-0.5-0.49-0.45-0.270.710.49-0.09-0.67-0.420.020.35-0.630.36-0.420.35-0.08-0.50.36-0.49-0.88-0.32
-0.750.95-0.04-0.62-0.95-0.940.61-0.870.160.92-0.36-0.050.620.250.35-0.760.96-0.581.0-0.53-0.930.99-0.95-0.48-0.95
1.0-0.880.40.650.910.88-0.080.59-0.27-0.860.680.14-0.110.07-0.63-0.76-0.80.85-0.780.670.93-0.770.910.890.72
-0.790.94-0.11-0.57-0.96-0.940.51-0.720.250.88-0.44-0.140.53-0.030.360.96-0.8-0.570.98-0.55-0.920.98-0.96-0.52-0.87
0.84-0.760.00.390.720.76-0.220.530.16-0.820.88-0.28-0.250.01-0.42-0.580.85-0.57-0.580.410.79-0.580.720.730.62
-0.770.95-0.06-0.61-0.96-0.950.58-0.830.190.91-0.39-0.080.60.160.351.0-0.780.98-0.58-0.54-0.941.0-0.96-0.5-0.93
0.68-0.50.640.890.590.5-0.130.46-0.06-0.450.39-0.05-0.14-0.09-0.08-0.530.67-0.550.41-0.540.61-0.520.590.420.5
0.92-0.970.20.620.970.96-0.40.82-0.2-0.950.580.06-0.43-0.12-0.5-0.930.93-0.920.79-0.940.61-0.930.970.710.92
-0.760.95-0.04-0.59-0.96-0.950.59-0.830.190.92-0.39-0.080.610.160.360.99-0.770.98-0.581.0-0.52-0.93-0.96-0.49-0.93
0.9-0.990.170.671.00.99-0.410.75-0.21-0.960.530.1-0.44-0.07-0.49-0.950.91-0.960.72-0.960.590.97-0.960.690.87
0.89-0.680.510.450.690.670.320.35-0.48-0.670.50.40.290.1-0.88-0.480.89-0.520.73-0.50.420.71-0.490.690.45
0.71-0.880.030.530.870.86-0.630.96-0.12-0.880.38-0.03-0.64-0.37-0.32-0.950.72-0.870.62-0.930.50.92-0.930.870.45
Click cells to compare fundamentals

Compass Therapeutics Account Relationship Matchups

Compass Therapeutics fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets30.4M51.9M153.8M199.6M156.9M120.5M
Short Long Term Debt Total14.9M9.3M4.0M2.9M1.7M1.6M
Other Current Liab494K510K7.9M8.3M(1.6M)(1.5M)
Total Current Liabilities9.8M10.1M10.6M16.2M7.8M11.5M
Total Stockholder Equity(118.6M)39.9M140.1M181.6M148.5M156.0M
Net Tangible Assets(118.6M)39.9M140.1M181.6M208.9M219.3M
Property Plant And Equipment Net3.8M1.1M6.3M4.5M2.7M3.2M
Net Debt(10.4M)(37.7M)(140.5M)(32.0M)(22.5M)(23.6M)
Retained Earnings(121.9M)(151.4M)(233.6M)(272.8M)(315.3M)(299.5M)
Accounts Payable629K1.1M867K3.4M4.1M2.2M
Cash25.3M47.1M144.5M34.9M24.2M44.5M
Non Current Assets Total4.1M1.7M6.7M4.9M3.0M3.5M
Other Assets392K583K0.0320K288K267.5K
Cash And Short Term Investments25.3M47.1M144.5M186.6M152.5M112.5M
Common Stock Total Equity3.3M5K10K13K11.7K11.1K
Liabilities And Stockholders Equity30.4M51.9M153.8M199.6M156.9M120.5M
Non Current Liabilities Total139.2M1.9M3.0M1.8M536.0K509.2K
Other Current Assets935K3.1M2.6M8.2M1.4M1.3M
Other Stockholder Equity3.3M191.3M373.7M454.7M463.8M273.3M
Total Liab149.0M12.0M13.7M18.0M8.3M7.9M
Net Invested Capital(103.7M)49.3M140.1M181.6M148.5M156.0M
Property Plant And Equipment Gross3.8M1.1M11.4M10.1M8.9M7.5M
Total Current Assets26.2M50.2M147.1M194.8M153.9M115.7M
Capital Stock3.3M5K10K13K11.7K11.1K
Net Working Capital16.4M40.1M136.5M178.6M146.1M104.2M
Short Term Debt5.6M7.5M989K1.1M1.2M1.1M
Common Stock3.3M5K10K13K11.7K11.1K
Property Plant Equipment3.8M1.1M6.3M1.6M1.4M1.3M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Compass Stock Analysis

When running Compass Therapeutics' price analysis, check to measure Compass Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Compass Therapeutics is operating at the current time. Most of Compass Therapeutics' value examination focuses on studying past and present price action to predict the probability of Compass Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Compass Therapeutics' price. Additionally, you may evaluate how the addition of Compass Therapeutics to your portfolios can decrease your overall portfolio volatility.